Jump to content

From Characterization to Quality Monitoring:
A Single End-to-End Platform for MAM
— Webinar for Japan

The Genedata Expressionist® Webinar "From Characterization to Quality Monitoring: A Single End-to-End Platform for MAM", held on May 5, 2021, will be hosted by Genedata KK on November 19, 2021 for researchers located in Japan.

Since the first Multi-Attribute-Method (MAM)-based submission was approved by the FDA in 2019, more and more biopharma companies are striving to leverage the efficiencies delivered by MAM to streamline their development and manufacturing processes. As a long-term member of the MAM Consortium, Genedata is spearheading the biopharma industry’s adoption of MAM approaches, and uses the experience, domain knowledge, and expertise it has gained to work closely with its partners to develop the MAM capabilities of Genedata Expressionist and make it the software of choice for MAM implementations.

In this webinar you will learn how new automated quality monitoring approaches further expand the MAM capabilities of Genedata Expressionist: the only end-to-end solution supporting the entire MAM process — from upstream in-depth characterization to downstream targeted critical quality attribute monitoring — on a single integrated software platform.

Highlights include:
  • An all-new solution for automated CQA monitoring
  • Streamlined and simplified method transfer from Development to Manufacturing and QC
  • Up- and downstream data integration for automating the entire MAM process
  • Naohiko Heida, Scientific Account Manager, Genedata KK (Japanese presentation)

November 19, 2021, 05:30 CET